In order to prevent the novel coronavirus, India has developed its vaccine called “Covaxin”. The trials of this vaccine in human body started on Friday.
A 30-year-old volunteer got the first dose of 0.5 mg of Covaxin at AIIMS Hospital in Delhi, Indian online portal NDTV reports.
According to NDTV, the young man will be kept under observation for seven days to find out how he is doing after applying the Covaxin and whether there are any side effects in his body.
Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS and the principal investigator of the study, said more than 3,500 volunteers had registered for the experimental use of the Covaxin since July 18.
Sanjay Rai said, “The young man, the first volunteer from Delhi, had to go through various tests two days ago. His health is fairly normal. Other than that, he has no health complications.”
Doctors kept the man under strict observation for the next seven days.
In the second phase, 750 people between the ages of 12 and 65 will get the vaccine, AIIMS Director Dr Randeep Guleria told PTI.
However, in all cases, Covaxin will be applied only after various tests on the body, not before.
On July 18, the AIIMS policy-making committee approved the use of the Covid-19 vaccine in a total of 100 people. However, in the first phase, a total of 365 people will receive the vaccine.
